Photocoagulation of early pelvic endometriosis with the Nd: YAG laser through the laparoscope.
Our prospective study evaluated the efficacy of the Nd:YAG laser (MMB-AT MediLas 2) for early-stage clinical endometriosis. Patients with suspected endometriosis underwent diagnostic laparoscopy, and if mild or moderate pelvic endometriosis was discovered, the lesions were treated with the Nd:YAG laser at a power setting of 20 w with intermittent, one- to three-second exposures. All the patients are being treated postoperatively with danazol (800 mg/day) for three to nine months. At this writing, 14 of 24 patients selected for laparoscopy were eligible for treatment with the Nd:YAG laser. Six weeks after treatment all the patients reported relief of their initial symptoms. To date, two patients have had repeat laparoscopy after Nd:YAG photocoagulation of mild endometriotic lesions. Neither patient had evidence of disease at the second laparoscopy.
Lomano
J M
JM
D003131:Combined Modality Therapy; D003613:Danazol / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D006801:Humans; D010535:Laparoscopy; D053685:Laser Therapy; D007834:Lasers; D010386:Pelvic Neoplasms / Q000188:drug therapy / Q000601:surgery*; D011446:Prospective Studies
D003613:Danazol